StockNews.AI
RBGLY
StockNews.AI
25 days

Shareholders that lost money on Reckitt Benckiser Group plc (RBGLY) should contact Levi & Korsinsky about pending Class Action - RBGLY

1. A class action lawsuit has been filed against Reckitt Benckiser Group plc. 2. Allegations include securities fraud affecting investors between January 2021 and July 2024. 3. The lawsuit claims Reckitt misrepresented risks linked to its Enfamil formula. 4. Investors can seek compensation without upfront costs through the lawsuit. 5. Levi & Korsinsky, LLP represents the plaintiffs in this case.

5m saved
Insight
Article

FAQ

Why Bearish?

The class action lawsuit indicates potential legal and financial liabilities, which may depress investor sentiment and stock prices. Historically, similar lawsuits have negatively impacted company valuations during litigation, causing stock declines.

How important is it?

The lawsuit's association with securities fraud and risks to Reckitt’s operations bears significant weight on investor perception and future stock performance.

Why Long Term?

Legal proceedings can take years, and ongoing liabilities may affect Reckitt's financial health and stock performance in the long-term, as resolution can lead to substantial settlements or judgments.

Related Companies

RBGLYPGUNVRELKMB
, /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/reckitt-benckiser-group-plc-lawsuit-submission-form?prid=157925&wire=4 RBGLY investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in Reckitt Benckiser Group plc during the relevant time frame, you have until August 4, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected]Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News